Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Dofetilide recalled?

Not under an active recall. Dofetilide was recalled 7 times in the past — all now closed. Most recent: Jul 18, 2023.

Most common reason: cGMP deviation (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dofetilide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Dofetilide recalls on record

none so far in 2026; 7 on record, newest first
Class II · Moderate risk

Dofetilide Capsules 500 mcg

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-492-12 D-0385-2023
Class II · Moderate risk

Dofetilide Capsules 250 mcg

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-491-12 D-0384-2023
Class II · Moderate risk

Dofetilide Capsules

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-490-12 D-0383-2023
Class II · Moderate risk

Tikosyn (dofetilide)

Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.

Terminated Failed specification Pfizer Inc. NDC 0069-5800-61 D-0292-2015
Class II · Moderate risk

Tikosyn¿ (dofetilide)

Presence of Foriegn Tablets/Capsules: A single Tikosyn¿ (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn¿ (dofetilide) 500 mcg (0.5 mg).

Terminated Particulate / foreign matter Pfizer Inc. NDC 00069-5820-60 D-1253-2014